Abstract:Abstract Abstract 652 Atherosclerosis, a major cause of cardiovascular disease, is a complicated chronic inflammatory process. A variety of data demonstrate that platelets are crucial players in this pathological process. Platelet activation results in a-granule secretion and the secreted materials include adhesive proteins, chemokines and growth factors, which attract and mediate continuous inflammatory cell attachment to, and infiltration of dysfunctional endothelium and atherosclerotic plaques. Here, we show that the ablation of P2Y12, an ADP receptor highly expressed in platelets and smooth muscle cells, can significantly decrease monocyte infiltration of the aortic root, and thereby negatively affect enlargement of the atherosclerotic lesion in ApoE−/− mice fed on a high fat diet for 5 months. Ablation of P2Y12 in ApoE−/− mice also stabilizes the atherosclerotic plaques that do form in the double knockout mice. Plaque stability was demonstrated by Immunohistochemistry studies that revealed greater fibrous and diminished macrophage content in the atherosclerotic plaques. Bone marrow transplantation experiments confirmed that platelet P2Y12, but not smooth muscle P2Y12, is the key factor responsible for atherosclerosis formation. Further work demonstrated that P2Y12, through inhibition of the cAMP/PKA signaling pathway, critically regulates platelet expression of p-selectin and the release of PF4. This demonstration is crucial because PF4 is a chemokine documented to be important for atherosclerosis development. The results of in vitro assays demonstrated that under standard conditions, P2Y12+/+ platelets, but not P2Y12−/− platelets, released their a-granule contents during platelet activation and thereby enhanced monocyte migration. Compared to results obtained using P2Y12+/+ApoE−/− mice under the same conditions, the basal levels of PF4 and SDF-1a in platelet-poor plasma were significantly lower in P2Y12−/−ApoE−/− double knockout mice fed a high-fat diet, thereby providing in vivo support for our thesis that P2Y12 affects atherogenesis by regulating a-granule secretion. Our results point out that platelet P2Y12 modulates atherogenesis primarily through regulation of a-granule release, and secondarily by the resulting inflammatory cell recruitment, and therefore serves as a potential drug target for atherosclerosis prevention, in addition to being the target for prevention of thrombus formation in response to plaque rupture. Disclosures: No relevant conflicts of interest to declare.

PROSTAGLANFIN E RECEPTORS AS INFLAMMATORY THERAPEUTIC TARGETS FOR ATHEROSCLEROSIS

Prostaglandin E Receptors As Inflammatory Therapeutic Targets for Atherosclerosis

Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis

Roles of the prostaglandin E 2 receptors EP subtypes in Alzheimer’s disease

Cyclooxygenase-2 expression, prostacyclin production and endothelial protection of high-density lipoprotein.

An Update of Microsomal Prostaglandin E Synthase-1 and PGE2Receptors in Cardiovascular Health and Diseases

Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy.

Prostaglandin receptor EP4 in abdominal aortic aneurysms

Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype

Programmed prodrug breaking the feedback regulation of P-selectin in plaque inflammation for atherosclerotic therapy

Atherosclerosis: cell biology and lipoproteins--new mechanistic links in atherosclerosis: chemokines mediating the effects of lipids, platelets and dendritic cells.

Endogenous Pro-Resolving and Anti-Inflammatory Lipid Mediators: the New Hope of Atherosclerotic Diseases.

Targeted Disruption of the Prostaglandin E2 E-prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice.

Platelet ADP Receptor P2Y12 Stabilizes Atherosclerosis Plaques by Regulating Alpha Granule Release and Inflammatory Cell Recruitment

Relationship between Secretory Phospholipase A2 of Group ⅡA and Atherosclerosis

Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells

Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation

Role of Mast Cells in Atherosclerosis: A Classical Inflammatory Disease

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

Therapeutic Targeting of Pattern Recognition Receptors to Modulate Inflammation in Atherosclerosis

EP3 Blockade Adds to the Effect of TP Deficiency in Alleviating Endothelial Dysfunction in Atherosclerotic Mouse Aortas